Bakoush Omran, Tencer Jan, Tapia Juan, Rippe Bengt, Torffvit Ole
Department of Nephrology and Department of Medicine, Lund University Hospital, Lund, Sweden.
Kidney Int. 2002 Jan;61(1):203-8. doi: 10.1046/j.1523-1755.2002.00108.x.
Proteinuria, due to impairment of the charge- and/or size selectivity of the glomerular capillary wall (GCW) is the earliest clinical evidence of diabetic nephropathy (DN). To study the pathophysiological differences between patients with DN in type 1 diabetes mellitus (type 1 DN) and type 2 diabetes mellitus (type 2 DN), we compared the patterns of urinary proteins of different size and charge in the two entities of diabetic kidney disease.
Urine concentrations of albumin, IgG2, IgG4 and IgM were assessed in 22 (15 males and 7 females) patients with type 1 DN, and in 20 (18 males and 2 females) patients with type 2 DN. Comparisons with one control group of 13 (12 males and one female) patients with nephrosclerosis due to systemic hypertension and a second control group of 16 (14 males and 2 females) healthy controls were made.
The urine excretion of IgG2 and IgM and the ratio of IgG2 to IgG4 (IgG2/IgG4), were significantly higher in type 2 DN compared to type 1 DN (P < 0.01). Patients with type 2 DN and patients with nephrosclerosis had significantly higher urine excretion of IgG and IgM compared to the age-matched healthy subjects (P < 0.001). The IgG2/IgG4 ratio was higher in type 2 DN compared to nephrosclerosis and healthy controls (P < 0.01).
The increased urine excretion of IgG and IgM that accompanies albuminuria in type 2 DN suggests that the dominant pathophysiological mechanism of proteinuria in type 2 DN might be an alteration of the size selective properties of the glomerular capillary wall, including the occurrence of non-discriminatory "shunt pathways." The charge selective properties of the glomerular capillary wall seem to be intact in type 2 DN, as indicated by the high IgG2/IgG4 ratio. The mechanisms of proteinuria in type 1 DN seem to be merely a consequence of an impaired charge selectivity of the glomerular capillary wall.
由于肾小球毛细血管壁(GCW)电荷和/或大小选择性受损导致的蛋白尿是糖尿病肾病(DN)最早的临床证据。为了研究1型糖尿病(1型DN)和2型糖尿病(2型DN)患者DN的病理生理差异,我们比较了两种糖尿病肾病实体中不同大小和电荷的尿蛋白模式。
评估了22例(15例男性和7例女性)1型DN患者以及20例(18例男性和2例女性)2型DN患者的尿白蛋白、IgG2、IgG4和IgM浓度。与一组13例(12例男性和1例女性)因系统性高血压导致肾硬化的对照组以及另一组16例(14例男性和2例女性)健康对照进行了比较。
与1型DN相比,2型DN中IgG2和IgM的尿排泄量以及IgG2与IgG4的比值(IgG2/IgG4)显著更高(P<0.01)。与年龄匹配的健康受试者相比,2型DN患者和肾硬化患者的IgG和IgM尿排泄量显著更高(P<0.001)。与肾硬化和健康对照相比,2型DN中的IgG2/IgG4比值更高(P<0.01)。
2型DN中伴随蛋白尿出现的IgG和IgM尿排泄量增加表明,2型DN中蛋白尿的主要病理生理机制可能是肾小球毛细血管壁大小选择性特性的改变,包括出现非选择性的“分流途径”。肾小球毛细血管壁的电荷选择性特性在2型DN中似乎是完整的,这由高IgG2/IgG4比值表明。1型DN中蛋白尿的机制似乎仅仅是肾小球毛细血管壁电荷选择性受损的结果。